Vertex Pharmaceuticals today announced that it has discovered two new classes of compounds that, in laboratory studies, partially restore the function of the defective cell membrane protein that is responsible for the progression of cystic fibrosis. more…

http://www.charitypartnership.com/resources/charities-chicago.html
Originally Posted on 2/2/2006 3:51:22 PM
Content source: http://www.charitywire.com/charity50/05792.html